Poland· PL-100219824
Venbig
A hepatitis b immunoglobulin product containing immunoglobulinum humanum hepatitidis b ad usum intravenosum, registered in Poland by Kedrion S.p.A.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Hepatitis b immunoglobulin is registered in 12 of 19 countries.
Countries holding a registration under ATC J06BB04 (hepatitis b immunoglobulin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Hepatitis b immunoglobulin · ATC J06BB04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Immunoglobulinum humanum hepatitidis B ad usum intravenosum
- Manufacturer
- Kedrion S.p.A.
- Country
- Poland (PL)
- ATC code
- J06BB04
- ATC class
- Hepatitis B immunoglobulin
- Defined daily dose
- 500 E, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990747856
- gtin05909990747863
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hepatitis b immunoglobulin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHepatect CP 100units/2ml solution for infusion vialsBiotest (UK) Ltd
- SwitzerlandHepatect CP, InfusionslösungBiotest (Schweiz) AG
- SpainHEPATECT 50 UI/ml SOLUCION PARA PERFUSIONBiotest Pharma Gmbh
- Japan乾燥抗ＨＢｓ人免疫グロブリン武田薬品工業
- FranceIMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB 100 UI/mL, solution injectable en seringue préremplie (IM)LFB-BIOMEDICAMENTS
- CanadaHEPAGAM BKI BIOPHARMA LLC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8133c085-6df3-47c8-abf0-b6c52fb7fd8c GET /v1/drugs/8133c085-6df3-47c8-abf0-b6c52fb7fd8c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i rozpuszczalnik do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "50 j.m./ml",
"packaging": "05909990747856 ¦ Lz ¦ 54814\n1 fiol. 500 j.m. proszku ¦ 1 zestaw do rekonstytucji i podania ¦ 1 fiol. 10 ml rozp.\n05909990747863 ¦ Lz ¦ 54815\n1 fiol. 2500 j.m. proszku ¦ 1 zestaw do rekonstytucji i podania ¦ 1 fiol. 45 ml rozp.\n¦ UR/Z/4c/110/24",
"substance": "Immunoglobulin human 50 mg/ml + Antibody anti Hbs nie mniej niż 50 j.m. + Immunoglobulinum co najmniej 95%",
"common_name": "Immunoglobulinum humanum hepatitidis B ad usum intravenosum",
"pl_product_id": "100219824",
"pozwolenie_nr": "16219",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about hepatitis b immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.